CD1D and colitis: Because EGFRi might also have effects independent of expansion of colonic iNKT cells that could impact colitis, we evaluated the effects of EGFRi treatment in mice with CD1d deficient goblet cells, where we did not observe colonic iNKT cell expansion after EGFRi treatment (Schematic Fig. 6h and data Fig. 4g).